Stony Brook, NY (PressExposure) September 23, 2011 -- inGenious Targeting Laboratory, Inc (iTL), and Umea University (Umea, Sweden) have partnered in a two year Master Institutional Service Agreement, further strengthening their ongoing relationship. Investigators from Umea University have been utilizing iTL's services since 2006. This agreement combines the research expertise of Umea University with the over 12 years of experience that iTL has generating custom mouse models.
"Providing one of Europe's premier universities with a one stop shop for these models will foster the efficient advancement of important research, while maintaining the highest quality iTL can offer" states iTL President and COO Paul Sheifelle.
Solidifying agreements such as these is an exciting step forward for iTL as they help propel them forward as a global leader in the transgenic mouse community. "Agreements like this help showcase our technical abilities as well as aid the research community at large" remarks Paul Sheifelle.
"This agreement will provide our scientists with ready access to iTL's customized services, at Umeå University we are committed to high quality research utilizing the latest technologies." states Leif Carlsson, Professor and Head of Animal Unit at Umeå University.
About Umea University
Umea University was founded in 1965 and is Sweden's fifth oldest university. With a strong international and multicultural presence with students, teachers and researchers from all over the world, Umea University is one of the leading comprehensive universities in Sweden. Umea has a strong interdisciplinary research environment, fostering the generation of high quality international research.
About inGenious Targeting Laboratory (iTL)
Established in 1998, inGenious Targeting Laboratory (iTL) has become a leading external provider of custom genetically modified mouse models. iTL exclusively creates mice whose genetic make-up is tailored to the client's research needs. iTL is dedicated to protecting their client's interests, and therefore retains no rights to the model or design; the same model will not be generated for or distributed to additional clients. All intellectual property belongs solely to the client.
With four robust Embryonic Stem Cell lines (BALB/c, C57BL/6N, 129SvEv and Hybrid), coupled with a highly experienced staff of over 40 gene targeting specialists, iTL provides superior quality that is highly dependable, detail oriented and extremely efficient. To date iTL has successfully delivered over 1,100 targeted models to academic institutions, pharmaceutical companies, biotechnology companies and government institutes worldwide.